Candel Therapeutics Inc. (NASDAQ: CADL) Stock Information | RedChip

Candel Therapeutics Inc. (NASDAQ: CADL) Listen to this Section


$5.50
+0.1200 ( +2.23% ) 69.1K

Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.

Market Data


Open


$5.50

Previous close


$5.38

Volume


69.1K

Market cap


$176.79M

Day range


$5.35 - $5.57

52 week range


$0.66 - $14.30

Insider Ownership Transactions

Total Amount Purchased: 0.00 | $ 0.00

Date Type Amount Purchased Purchaser
No records found.

SEC Fillings


Form Type Description Pages Date
10-q Quarterly Reports 81 Aug 10, 2023

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.